223 results on '"Maisel, Alan"'
Search Results
2. Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides
3. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure
4. Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial
5. Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status
6. Decongestion, kidney injury and prognosis in patients with acute heart failure
7. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
8. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
9. Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
10. Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure
11. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure
12. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
13. Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
14. Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction
15. Persistent Value of the Stethoscope in the Age of COVID-19
16. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])
17. Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse
18. Aseptic Barriers Allow a Clean Contact for Contaminated Stethoscope Diaphragms
19. The Impact of Substance Abuse on Heart Failure Hospitalizations
20. Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure
21. Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure
22. Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS)
23. Observation of stethoscope sanitation practices in an emergency department setting
24. The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?
25. Toward Precision Medicine in the Cardiorenal Syndrome
26. Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study)
27. Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
28. Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial
29. Troponin in Heart Failure
30. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides
31. Clinical Applications of Biomarkers in Atrial Fibrillation
32. Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis)
33. Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
34. Practical approach on frail older patients attended for acute heart failure
35. Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine
36. Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis
37. Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure
38. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial
39. Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure
40. Multimarker Testing With ST2 in Chronic Heart Failure
41. Serial ST2 Testing in Hospitalized Patients With Acute Heart Failure
42. ST2 and Multimarker Testing in Acute Decompensated Heart Failure
43. The Potential Role of Natriuretic Peptide–Guided Management for Patients Hospitalized for Heart Failure
44. The Utility of Galectin-3 for Predicting Cause-Specific Death in Hospitalized Patients With Heart Failure
45. Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction
46. Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study)
47. Novel Biomarkers in Heart Failure with Preserved Ejection Fraction
48. Chapitre 24 - Biomarqueurs dans l'insuffisance cardiaque aiguë
49. The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: The Multi-Ethnic Study of Atherosclerosis
50. Proenkephalin and Prognosis After Acute Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.